These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 14679096)

  • 1. Detection of GAD-reactive CD4+ cells in so-called "type 1B" diabetes.
    Shimada A; Kodama K; Morimoto J; Oikawa Y; Irie J; Nakagawa Y; Matsubara K; Maruyama T; Saruta T
    Ann N Y Acad Sci; 2003 Nov; 1005():378-86. PubMed ID: 14679096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GAD-reactive T cells were mainly detected in autoimmune-related type 1 diabetic patients with HLA DR9.
    Itoh A; Shimada A; Kodama K; Morimoto J; Suzuki R; Oikawa Y; Irie J; Nakagawa Y; Shigihara T; Kanazawa Y; Okubo Y; Motohashi Y; Maruyama T; Saruta T
    Ann N Y Acad Sci; 2004 Dec; 1037():33-40. PubMed ID: 15699491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Detection of GAD65 reactive T cells in some Chinese subjects initially diagnosed as with idiopathic type 1 diabetes].
    Zhang Y; Zhou ZG; Yang L; Zhou HF; Lin J; Sun Y; Huang G
    Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(16):1102-5. PubMed ID: 17672990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated serum IP-10 levels observed in type 1 diabetes.
    Shimada A; Morimoto J; Kodama K; Suzuki R; Oikawa Y; Funae O; Kasuga A; Saruta T; Narumi S
    Diabetes Care; 2001 Mar; 24(3):510-5. PubMed ID: 11289477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracellular IFN-gamma production and IL-12 serum levels in latent autoimmune diabetes of adults (LADA) and in type 2 diabetes.
    Tsiavou A; Degiannis D; Hatziagelaki E; Koniavitou K; Raptis SA
    J Interferon Cytokine Res; 2004 Jul; 24(7):381-7. PubMed ID: 15296648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epitope analysis of GAD65 autoantibodies in Japanese patients with autoimmune diabetes.
    Kawasaki E; Abiru N; Ide A; Sun F; Fukushima T; Takahashi R; Kuwahara H; Fujita N; Kita A; Oshima K; Uotani S; Yamasaki H; Yamaguchi Y; Eguchi K
    Ann N Y Acad Sci; 2003 Nov; 1005():440-8. PubMed ID: 14679108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two cases of "fulminant" type 1 diabetes suggesting involvement of autoimmunity.
    Nakagawa Y; Shimada A; Oikawa Y; Irie J; Shigihara T; Tsumura K; Narumi S; Saruta T
    Ann N Y Acad Sci; 2003 Nov; 1005():359-61. PubMed ID: 14679092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Both CD4+ and CD8+ T-cells in syngeneic islet grafts in NOD mice produce interferon-gamma during beta-cell destruction.
    Suarez-Pinzon W; Rajotte RV; Mosmann TR; Rabinovitch A
    Diabetes; 1996 Oct; 45(10):1350-7. PubMed ID: 8826970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined analysis of islet cell antibodies that cross-react with mouse pancreas, antibodies to the M(r) 64,000 islet protein, and antibodies to glutamate decarboxylase in type I diabetic patients.
    Chaillous L; Delamaire M; Martignat L; Maugendre D; Marre M; Mathieu E; Limal JM; Charbonnel B; Allannic H; Saï P
    Diabetes Care; 1994 Oct; 17(10):1115-23. PubMed ID: 7821130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GAD-alum treatment induces GAD65-specific CD4+CD25highFOXP3+ cells in type 1 diabetic patients.
    Hjorth M; Axelsson S; Rydén A; Faresjö M; Ludvigsson J; Casas R
    Clin Immunol; 2011 Jan; 138(1):117-26. PubMed ID: 21044870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The combination of antibodies to GAD-65 and IA-2ic can replace the islet-cell antibody assay to identify subjects at risk of type 1 diabetes mellitus.
    Hatziagelaki E; Jaeger C; Petzoldt R; Seissler J; Scherbaum WA; Federlin K; Bretzel RG
    Horm Metab Res; 1999 Oct; 31(10):564-9. PubMed ID: 10596966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Value of glutamic acid decarboxylase autoantibody detection for early diagnosis of latent autoimmune diabetes in adults].
    Huang YY; Huang P; Lou HL
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Aug; 23(8):868-9. PubMed ID: 12919925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Demonstration of GAD-65 as the main immunogenic isoform of glutamate decarboxylase in type 1 diabetes and determination of autoantibodies using a radioligand produced by eukaryotic expression.
    Velloso LA; Kämpe O; Hallberg A; Christmanson L; Betsholtz C; Karlsson FA
    J Clin Invest; 1993 May; 91(5):2084-90. PubMed ID: 8486775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T cell immunity to glutamic acid decarboxylase in fulminant type 1 diabetes without significant elevation of serum amylase.
    Aoki K; Taniyama M; Nagayama C; Oikawa Y; Shimada A
    Ann N Y Acad Sci; 2006 Oct; 1079():181-5. PubMed ID: 17130552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of GAD65-reactive T-Cells in type 1 diabetes by immunoglobulin-free ELISPOT assays.
    Kotani R; Nagata M; Moriyama H; Nakayama M; Yamada K; Chowdhury SA; Chakrabarty S; Jin Z; Yasuda H; Yokono K
    Diabetes Care; 2002 Aug; 25(8):1390-7. PubMed ID: 12145240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Islet glutamic acid decarboxylase modified by reactive oxygen species is recognized by antibodies from patients with type 1 diabetes mellitus.
    Trigwell SM; Radford PM; Page SR; Loweth AC; James RF; Morgan NG; Todd I
    Clin Exp Immunol; 2001 Nov; 126(2):242-9. PubMed ID: 11703367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GAD-reactive CD4+ Th1 cells induce diabetes in NOD/SCID mice.
    Zekzer D; Wong FS; Ayalon O; Millet I; Altieri M; Shintani S; Solimena M; Sherwin RS
    J Clin Invest; 1998 Jan; 101(1):68-73. PubMed ID: 9421467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The type and frequency of immunoregulatory CD4+ T-cells govern the efficacy of antigen-specific immunotherapy in nonobese diabetic mice.
    Pop SM; Wong CP; He Q; Wang Y; Wallet MA; Goudy KS; Tisch R
    Diabetes; 2007 May; 56(5):1395-402. PubMed ID: 17317763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Islet cell cytoplasmic autoantibody reactivity to glutamate decarboxylase in insulin-dependent diabetes.
    Atkinson MA; Kaufman DL; Newman D; Tobin AJ; Maclaren NK
    J Clin Invest; 1993 Jan; 91(1):350-6. PubMed ID: 8423231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence of a broad repertoire of GAD65-specific T-cells in type 1 diabetes patients with graft dysfunction after allogeneic islet transplantation.
    Chujo D; Foucat E; Takita M; Itoh T; Sugimoto K; Shimoda M; Yagi K; Yamagishi M; Tamura Y; Yu L; Naziruddin B; Levy MF; Ueno H; Matsumoto S
    Cell Transplant; 2012; 21(12):2783-95. PubMed ID: 22963904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.